Page last updated: 2024-12-08

carnosol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carnosol: isolated from Lepechinia hastata [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Lepechiniagenus[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Lepechinia hastataspecies[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]

Cross-References

ID SourceID
PubMed CID442009
CHEMBL ID218693
CHEBI ID3429
SCHEMBL ID42365
MeSH IDM0187581

Synonyms (36)

Synonym
nsc-39143
2h-9,4a-(epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar-(4aalpha,9alpha,10abeta))-
ccris 7122
carnosol
5957-80-2
C09069
CHEMBL218693 ,
chebi:3429 ,
bdbm50213683
hsdb 7680
nsc 39143
unii-483o455ckd
483o455ckd ,
S9127
AKOS015897159
BRD-K67265981-001-01-5
CCG-208130
SCHEMBL42365
carnosol [hsdb]
2h-9,4a-(epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar-(4a.alpha.,9.alpha.,10a.beta.))-
carnosol (constituent of rosemary) [dsc]
picrosalvin
podocarpa-8,11,13-trien-17-oic acid, 7.beta.,11,12-trihydroxy-13-isopropyl-, 17,7-lactone
2h-9,4a-(epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4ar,9s,10as)-
carnosol [mi]
AC-34727
1,3,4,9,10,10as-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-isopropyl-2h-9s,4ar-(epoxymethano)phenanthren-12-one
mfcd02752467
(1r,8s,10s)-3,4-dihydroxy-11,11-dimethyl-5-(propan-2-yl)-16-oxatetracyclo[6.6.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-trien-15-one
carnosol, analytical standard
DTXSID80904451
(4ar,9s,10as)-5,6-dihydroxy-7-isopropyl-1,1-dimethyl-2,3,4,9,10,10a-hexahydro-1h-9,4a-(epoxymethano)phenanthren-12-one
HY-N0643
CS-0009670
Q16634054
(1r,8s,10s)-3,4-dihydroxy-11,11-dimethyl-5-propan-2-yl-16-oxatetracyclo[6.6.2.01,10.02,7]hexadeca-2,4,6-trien-15-one

Research Excerpts

Overview

Carnosol (CAR) is a kind of diterpenoid with antioxidant, anti-inflammatory and antitumor activities. Carnosol is an orthodiphenolic diterpene that has been extensively applied in traditional medicine for the treatment of autoimmune and inflammatory diseases.

ExcerptReferenceRelevance
"Carnosol (CAR) is a kind of diterpenoid with antioxidant, anti-inflammatory and antitumor activities."( Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3.
Geng, Y; Hu, Y; Kang, X; Sun, R; Sun, Y; Tian, X; Wang, Y; Wang, Z; Yao, J; Zhao, H; Zhao, Y; Zhu, M, 2021
)
2.79
"Carnosol is a phytopolyphenol (diterpene) found and extracted from plants of Mediterranean diet, which has anti-tumor, anti-inflammatory and antioxidant effects. "( Carnosol inhibits cerebral ischemia-reperfusion injury by promoting AMPK activation.
She, ZG; Tu, J; Wan, L; Wang, L; Xiao, WC; Xu, CL; Yu, YJ; Zhou, G, 2023
)
3.8
"Carnosol is a plant-derived polyphenol that has been proven to exhibit several cell protective effects."( Carnosol inhibits KGN cells oxidative stress and apoptosis and attenuates polycystic ovary syndrome phenotypes in mice through Keap1-mediated Nrf2/HO-1 activation.
Chen, X; Gao, Y; Ji, R; Jia, F; Yang, J, 2023
)
3.07
"Carnosol is a phenolic diterpene purified from the herbs such as rosemary and Mountain desert sage and has been shown to have anticancer activities in multiple cancers."( Downregulation of SODD mediates carnosol-induced reduction in cell proliferation in esophageal adenocarcinoma cells.
Cao, W; Li, A, 2023
)
1.92
"Carnosol is an orthodiphenolic diterpene that has been extensively applied in traditional medicine for the treatment of multiple autoimmune and inflammatory diseases."( Carnosol Alleviates Collagen-Induced Arthritis by Inhibiting Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T Cells.
Chen, J; Li, F; Li, H; Luo, Y; Sun, N; Tian, J; Wang, H; Zhang, L; Zheng, S, 2023
)
3.07
"Carnosol is a natural compound with pharmacological action due to its anti-cancer properties. "( Critical roles of tyrosyl-DNA phosphodiesterases in cell tolerance to carnosol-induced DNA damage.
Bai, X; Feng, X; Liu, X; Qing, Y; Takeda, S; Wu, X; Wu, Y; Xiang, C; Zhao, J; Zhao, Z, 2020
)
2.23
"Carnosol is a natural phenolic diterpene with anti-inflammatory, antibacterial, anti-tumor and antioxidant properties."( Carnosol attenuates RANKL-induced osteoclastogenesis in vitro and LPS-induced bone loss.
Chen, Y; Hong, J; Hu, B; Jiang, G; Li, S; Lu, J; Yan, S; Yang, Q; Zhang, C; Zhou, C, 2020
)
2.72
"Carnosol (CS) is a bioactive diterpene compound present in Lamiaceae spp., which has been demonstrated to have antioxidant, anti-inflammatory, and anticancer properties."( Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
Gu, X; Li, Y; Liu, X; Lu, S; Ma, M; Shen, Q; Zhang, L; Zhang, W; Zhang, X, 2021
)
2.79
"Carnosol is an anti-oxidant and anti-inflammatory compound from rosemary. "( Carnosol-Induced ROS Inhibits Cell Viability of Human Osteosarcoma by Apoptosis and Autophagy.
Chang, IL; Chen, CL; Chen, HY; Cheng, CH; Hsieh, CP; Huang, YF; Lin, YC; Lo, YC; Wu, CC, 2017
)
3.34
"Carnosol is a natural compound extracted from rosemary and sage, which has been demonstrated to have anti-inflammatory, anti-oxidant, and anti-cancer properties. "( The Mechanisms of Carnosol in Chemoprevention of Ultraviolet B-Light-Induced Non-Melanoma Skin Cancer Formation.
Tong, L; Wu, S, 2018
)
2.26
"Carnosol is a naturally occurring herbal compound, known for its antioxidative properties. "( Carnosol suppresses interleukin-6 production in mouse lungs injured by ischemia-reperfusion operation and in RAW264.7 macrophages treated with lipopolysaccharide.
Funaki, S; Itoh, Y; Kanzaki, R; Kawamura, T; Minami, M; Momozane, T; Okumura, M; Ose, N; Sanosaka, M; Sasaki, T; Shintani, Y; Takemori, H, 2018
)
3.37
"Carnosol is an oxidative product of carnosic acid, whose presence in the extract was also confirmed by an authentic reference."( Callicarpa longissima extract, carnosol-rich, potently inhibits melanogenesis in B16F10 melanoma cells.
Fuchino, H; Iida, O; Itoh, Y; Kagawa, M; Kawahara, H; Kawahara, N; Kumagai, A; Kuroi, A; Nagaoka, Y; Sugimura, K; Takemori, H; Watanabe, H; Yamahara, M, 2016
)
1.44
"Carnosol is an ortho-diphenolic diterpene with excellent antioxidant potential. "( Carnosol protects against spinal cord injury through Nrf-2 upregulation.
Cheng, AB; Hou, YB; Ma, BY; Qiu, XH; Tian, L; Wang, ZH; Xie, YX; Zhang, JW, 2016
)
3.32
"Carnosol (CS) is an ortho-diphenolic diterpene in rosemary with great antioxidant potential. "( Evaluation of Antidiabetic Activity of Carnosol (Phenolic Diterpene in Rosemary) in Streptozotocin-Induced Diabetic Rats.
Borji, A; Farkhondeh, T; Samarghandian, S, 2017
)
2.17
"Carnosol is a phenolic diterpene that has potent antioxidant and anti-inflammatory activities. "( Protective effect of carnosol on lung injury induced by intestinal ischemia/reperfusion.
Guo, XH; Liu, KX; Tian, XF; Wang, LM; Wang, ZZ; Yao, JH; Zhang, XS; Zheng, SS, 2010
)
2.12
"Carnosol is a naturally occurring phytopolyphenol found in rosemary. "( Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages.
Ho, CT; Liang, YC; Lin, JK; Lin-Shiau, SY; Lo, AH, 2002
)
3.2

Effects

Carnosol has potential as a glucose homeostasis regulating agent. Has been proved to have anti-breast cancer effect in previous research.

ExcerptReferenceRelevance
"Carnosol has a protective effect on ischemic stroke, and this effect is achieved through AMPK activation. "( Carnosol inhibits cerebral ischemia-reperfusion injury by promoting AMPK activation.
She, ZG; Tu, J; Wan, L; Wang, L; Xiao, WC; Xu, CL; Yu, YJ; Zhou, G, 2023
)
3.8
"Carnosol has a protective effect on ischemic stroke, and this effect is achieved through AMPK activation. "( Carnosol inhibits cerebral ischemia-reperfusion injury by promoting AMPK activation.
She, ZG; Tu, J; Wan, L; Wang, L; Xiao, WC; Xu, CL; Yu, YJ; Zhou, G, 2023
)
3.8
"Carnosol has potential as a glucose homeostasis regulating agent and deserves further study."( Carnosol Increases Skeletal Muscle Cell Glucose Uptake via AMPK-Dependent GLUT4 Glucose Transporter Translocation.
Baron, D; MacPherson, REK; Tsiani, E; Vlachogiannis, IA; Vlavcheski, F, 2018
)
2.64
"Carnosol has been demonstrated to possess anti-inflammatory properties."( Carnosol inhibits cell adhesion molecules and chemokine expression by tumor necrosis factor-α in human umbilical vein endothelial cells through the nuclear factor-κB and mitogen-activated protein kinase pathways.
Chen, Y; He, X; Lan, P; Lian, L; Wu, X; Yao, H; Zhang, L, 2014
)
2.57
"Carnosol has been proved to have anti-breast cancer effect in previous research. "( [Effect of carnosol against proliferative activity of breast cancer cells and its estrogen receptor subtype's mediation and regulation mechanisms].
Lee, DY; Ma, ZZ; Niu, JZ; Sun, YL; Tao, SY; Zang, JF; Zhao, PW, 2014
)
2.23
"Carnosol has potent in vitro antimicrobial activity."( Traditional medicine of Baja California Sur (Mexico). III. Carnosol: a diterpene antibiotic from Lepechinia hastata.
Christophersen, C; Dimayuga, RE; Garcia, SK; Nielsen, PH, 1991
)
1.25

Actions

Carnosol can inhibit the planktonic growth and virulence factors of C. elegans. It can also inhibit the biofilm formation and development of the bacterium.

ExcerptReferenceRelevance
"Carnosol can also inhibit the biofilm formation and development of C."( Carnosol inhibits the growth and biofilm of Candida albicans.
Liu, X; Ma, T; Ma, Z; Sui, Y; Yang, L; Zhong, L, 2022
)
2.89
"Carnosol can inhibit the planktonic growth and virulence factors of C. "( Carnosol inhibits the growth and biofilm of Candida albicans.
Liu, X; Ma, T; Ma, Z; Sui, Y; Yang, L; Zhong, L, 2022
)
3.61

Treatment

Carnosol treatment significantly reduced malondialdehyde, nitric oxide, protein carbonyl, tumor necrosis factor- α, interleukin-6 levels and myeloperoxidase activity in the lungs of rats exposed to bleomycin. Carnosol pretreatment lowered the IL-6 protein levels in mouse lung homogenates prepared after the clamp-reperfusion.

ExcerptReferenceRelevance
"Carnosol treatment significantly reduced malondialdehyde, nitric oxide, protein carbonyl, tumor necrosis factor- α, interleukin-6 levels and myeloperoxidase activity in the lungs of rats exposed to bleomycin. "( Carnosol attenuates bleomycin-induced lung damage via suppressing fibrosis, oxidative stress and inflammation in rats.
Abolnezhadian, F; Basir, Z; Goudarzi, M; Hemmati, AA; Kalantar, H; Kalantar, M; Sadeghi, E, 2021
)
3.51
"Carnosol treatment also elevates the level of the RNA binding motif protein 24 (RBM24) and RNA binding motif protein 38 (RBM38) proteins, two multifunctional RNA-binding proteins."( Carnosol, a diterpene present in rosemary, increases ELP1 levels in familial dysautonomia patient-derived cells and healthy adults: a possible therapy for FD.
Anderson, SL; Evans, AJ; Fasih-Ahmad, F; Rubin, BY, 2022
)
2.89
"Carnosol treatment reduced the modifications in the stressed animals as compared with the control groups (P < 0.001)."( Protective effects of carnosol against oxidative stress induced brain damage by chronic stress in rats.
Azimi-Nezhad, M; Borji, A; Farkhondeh, T; Samarghandian, S; Samini, M, 2017
)
1.49
"Carnosol pretreatment lowered the IL-6 protein levels in mouse lung homogenates prepared after the clamp-reperfusion."( Carnosol suppresses interleukin-6 production in mouse lungs injured by ischemia-reperfusion operation and in RAW264.7 macrophages treated with lipopolysaccharide.
Funaki, S; Itoh, Y; Kanzaki, R; Kawamura, T; Minami, M; Momozane, T; Okumura, M; Ose, N; Sanosaka, M; Sasaki, T; Shintani, Y; Takemori, H, 2018
)
2.64
"Carnosol pretreatment significantly reduced renal dysfunction and histologic damage induced by renal IRI."( Carnosol protects against renal ischemia-reperfusion injury in rats.
Zhang, N; Zhang, Y; Zheng, Y, 2018
)
2.64
"Carnosol treatment also caused a dose-dependent increase in the levels of phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2)."( Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer.
AbuQamar, S; Al Dhaheri, Y; Arafat, K; Attoub, S; Bajbouj, K; Eid, A; Iratni, R; Karuvantevida, N; Ramadan, G, 2014
)
2.57
"Carnosol treatment showed reduction of nuclear factor-kappaB (NF-kappaB) subunits translocation and NF-kappaB DNA binding activity in activated macrophages."( Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages.
Ho, CT; Liang, YC; Lin, JK; Lin-Shiau, SY; Lo, AH, 2002
)
2.48
"Treatment with carnosol can modulate biochemical and histological alterations caused by bleomycin. "( Carnosol attenuates bleomycin-induced lung damage via suppressing fibrosis, oxidative stress and inflammation in rats.
Abolnezhadian, F; Basir, Z; Goudarzi, M; Hemmati, AA; Kalantar, H; Kalantar, M; Sadeghi, E, 2021
)
2.42
"Treatment with carnosol could also effectively regulate the adhesion and cytoskeleton."( A transcriptomics and molecular biology based investigation reveals the protective effect and mechanism of carnosol on t-BHP induced HRMECs via Nrf2 signaling pathway.
Chen, Z; Feng, W; Liu, K; Liu, Y; Lv, T; Ren, Y; Shu, Z; Zhang, Y, 2022
)
1.27
"Pretreatment with carnosol markedly reduced lung injury by increasing the tissue superoxide activity and decreasing the myeloperoxidase activity and interleukin-6 level, which was parallel to the decreased expression of ICAM-1 and NF-kappaB."( Protective effect of carnosol on lung injury induced by intestinal ischemia/reperfusion.
Guo, XH; Liu, KX; Tian, XF; Wang, LM; Wang, ZZ; Yao, JH; Zhang, XS; Zheng, SS, 2010
)
1
"Treatment with carnosol but not RA blocked increased binding of AP-1 to the COX-2 promoter."( Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms.
Cole, PA; Dannenberg, AJ; Subbaramaiah, K, 2002
)
1.01

Pharmacokinetics

ExcerptReferenceRelevance
"Rosemary (Salvia Rosmarinus) is a rich source of dietary diterpenes with carnosol as one of the major polyphenols used to standardize rosemary extracts approved as a food preservative, however, at present there is not any information on the murine pharmacokinetic profile of carnosol or its potential for drug interactions."( Pharmacokinetic characterization of carnosol from rosemary (Salvia Rosmarinus) in male C57BL/6 mice and inhibition profile in human cytochrome P450 enzymes.
Flowers, SA; Johnson, JJ; Nauman, MC; Tocmo, R; Veenstra, JP; Vemu, B, 2021
)
1.13

Bioavailability

ExcerptReferenceRelevance
" The aim of this study was to investigate the bioavailability of these compounds in a rat model of obesity."( Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats.
Espín, JC; Flanagan, J; Fromentin, E; García Villalba, R; García-Conesa, MT; Larrosa, M; Roller, M; Romo Vaquero, M; Tomás-Barberán, FA; Yáñez-Gascón, MJ, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diterpenoidAny terpenoid derived from a diterpene. The term includes compounds in which the C20 skeleton of the parent diterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin E synthaseHomo sapiens (human)IC50 (µMol)5.00000.00102.030810.0000AID1357408
Farnesyl pyrophosphate synthaseHomo sapiens (human)IC50 (µMol)13.30000.00020.71099.3600AID1617557
Pancreatic triacylglycerol lipaseHomo sapiens (human)IC50 (µMol)13.00000.00600.32530.7800AID311041
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processProstaglandin E synthaseHomo sapiens (human)
prostaglandin metabolic processProstaglandin E synthaseHomo sapiens (human)
signal transductionProstaglandin E synthaseHomo sapiens (human)
cell population proliferationProstaglandin E synthaseHomo sapiens (human)
negative regulation of cell population proliferationProstaglandin E synthaseHomo sapiens (human)
sensory perception of painProstaglandin E synthaseHomo sapiens (human)
regulation of fever generationProstaglandin E synthaseHomo sapiens (human)
positive regulation of prostaglandin secretionProstaglandin E synthaseHomo sapiens (human)
regulation of inflammatory responseProstaglandin E synthaseHomo sapiens (human)
cellular oxidant detoxificationProstaglandin E synthaseHomo sapiens (human)
cholesterol biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
geranyl diphosphate biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
farnesyl diphosphate biosynthetic processFarnesyl pyrophosphate synthaseHomo sapiens (human)
lipid metabolic processPancreatic triacylglycerol lipaseHomo sapiens (human)
intestinal cholesterol absorptionPancreatic triacylglycerol lipaseHomo sapiens (human)
retinol metabolic processPancreatic triacylglycerol lipaseHomo sapiens (human)
positive regulation of triglyceride lipase activityPancreatic triacylglycerol lipaseHomo sapiens (human)
lipid catabolic processPancreatic triacylglycerol lipaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
glutathione transferase activityProstaglandin E synthaseHomo sapiens (human)
glutathione peroxidase activityProstaglandin E synthaseHomo sapiens (human)
prostaglandin-D synthase activityProstaglandin E synthaseHomo sapiens (human)
protein bindingProstaglandin E synthaseHomo sapiens (human)
glutathione bindingProstaglandin E synthaseHomo sapiens (human)
prostaglandin-E synthase activityProstaglandin E synthaseHomo sapiens (human)
RNA bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
protein bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
metal ion bindingFarnesyl pyrophosphate synthaseHomo sapiens (human)
dimethylallyltranstransferase activityFarnesyl pyrophosphate synthaseHomo sapiens (human)
geranyltranstransferase activityFarnesyl pyrophosphate synthaseHomo sapiens (human)
triglyceride lipase activityPancreatic triacylglycerol lipaseHomo sapiens (human)
lipase activityPancreatic triacylglycerol lipaseHomo sapiens (human)
metal ion bindingPancreatic triacylglycerol lipaseHomo sapiens (human)
all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activityPancreatic triacylglycerol lipaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
nuclear envelope lumenProstaglandin E synthaseHomo sapiens (human)
endoplasmic reticulum membraneProstaglandin E synthaseHomo sapiens (human)
membraneProstaglandin E synthaseHomo sapiens (human)
perinuclear region of cytoplasmProstaglandin E synthaseHomo sapiens (human)
membraneProstaglandin E synthaseHomo sapiens (human)
nucleoplasmFarnesyl pyrophosphate synthaseHomo sapiens (human)
cytosolFarnesyl pyrophosphate synthaseHomo sapiens (human)
cytoplasmFarnesyl pyrophosphate synthaseHomo sapiens (human)
extracellular regionPancreatic triacylglycerol lipaseHomo sapiens (human)
extracellular spacePancreatic triacylglycerol lipaseHomo sapiens (human)
extracellular spacePancreatic triacylglycerol lipaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (72)

Assay IDTitleYearJournalArticle
AID1617557Inhibition of human N-terminal TEV protease cleavage site-fused-His6-tagged FPPS expressed in Escherichia coli BL21 (DE3) using GPP and IPP as substrate preincubated for 30 mins followed by substrate addition by continuous spectrophotometric assay2019Journal of medicinal chemistry, 12-12, Volume: 62, Issue:23
Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.
AID277542Cytotoxicity against human MCF7 cells at 650 uM2007Journal of natural products, Feb, Volume: 70, Issue:2
Bioactive diterpenes from Orthosiphon labiatus and Salvia africana-lutea.
AID380262Cytotoxicity against human SW1573 cells after 48 hrs by SRB assay2006Journal of natural products, Dec, Volume: 69, Issue:12
Abietane diterpenoids from Salvia pachyphylla and S. clevelandii with cytotoxic activity against human cancer cell lines.
AID1756074Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID744357Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons after 48 hrs by human placental alkaline phosphatase reporter gene assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1756067Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756071Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 40 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471596Antibacterial activity against Escherichia coli ATCC 9637 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471356Antibacterial activity against Bacillus cereus ATCC 21772 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756068Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471608Cytotoxicity against african green monkey Vero cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID335105Inhibition of pig pepsin up to 10 ug/ml1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID471603Cytotoxicity against human Hep2 cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID380263Cytotoxicity against human WiDr cells after 48 hrs by SRB assay2006Journal of natural products, Dec, Volume: 69, Issue:12
Abietane diterpenoids from Salvia pachyphylla and S. clevelandii with cytotoxic activity against human cancer cell lines.
AID471358Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756076Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID471601Cytotoxicity against human HeLa cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756070Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471609Cytotoxicity against african green monkey Vero cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756062Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756065Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID744351Induction of Nrf2/ARE-mediated GCLC gene expression in E15 stage mouse primary cortical neurons at 20 uM after 24 hrs by qPCR analysis2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID471605Cytotoxicity against human A549 cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID311041Inhibition of pancreatic lipase2007Bioorganic & medicinal chemistry, Jul-15, Volume: 15, Issue:14
The biology and chemistry of hyperlipidemia.
AID471607Cytotoxicity against human sMCF7 cells at exponential phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1246299Cytotoxicity against HEK293 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1756084Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 80 ug/ml measured after 48 hrs by MTT assay relative to control
AID744345Neuroprotective activity against H2O2-induced oxidative stress in E15 stage mouse primary cortical neurons at 20 uM incubated for 48 hrs prior to H2O2-treatment measured after 24 hrs by TUNEL/DAPI staining-based microscopic analysis2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1246301Antiproliferative activity against human triple-negative MDA-MB-231 cells at 22 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1756066Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756075Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756083Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 40 ug/ml measured after 48 hrs by MTT assay relative to control
AID335102Inhibition of bovine spleen cathepsin D up to 10 ug/ml1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID335901Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2002Journal of natural products, Sep, Volume: 65, Issue:9
Oxidation, reduction, and methylation of carnosic acid by Nocardia.
AID471357Antibacterial activity against Candida albicans CECT 170 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID744352Induction of Nrf2/ARE-mediated NQO1 gene expression in E15 stage mouse primary cortical neurons at 20 uM after 24 hrs by qPCR analysis2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1756069Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471606Cytotoxicity against human MCF7 cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756072Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 80 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756073Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID744353Cytotoxicity against E15 stage mouse primary cortical neurons at 50 uM by MTS assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID471604Cytotoxicity against human A549 cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID744347Neuroprotective activity against H2O2-induced toxicity in E15 stage mouse primary cortical neurons at 20 uM incubated for 48 hrs prior to H2O2-treatment measured after 24 hrs by MTS assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID744355Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons at 50 uM after 48 hrs by human placental alkaline phosphatase reporter gene2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID471600Cytotoxicity against human HeLa cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471359Antibacterial activity against Mycobacterium smegmatis ATCC 19420 after 48 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID380261Cytotoxicity against human A2780 cells after 48 hrs by SRB assay2006Journal of natural products, Dec, Volume: 69, Issue:12
Abietane diterpenoids from Salvia pachyphylla and S. clevelandii with cytotoxic activity against human cancer cell lines.
AID471598Antibacterial activity against Pseudomonas aeruginosa AK958 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID744350Induction of Nrf2/ARE-mediated GCLM gene expression in E15 stage mouse primary cortical neurons at 20 uM after 24 hrs by qPCR analysis2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID335101Inhibition of HIV1 recombinant protease expressed in Escherichia coli BL21 (DE3) cells by SDS-PAGE1993Journal of natural products, Aug, Volume: 56, Issue:8
Inhibitory effect of carnosic acid on HIV-1 protease in cell-free assays [corrected].
AID380264Cytotoxicity against human T47D cells after 48 hrs by SRB assay2006Journal of natural products, Dec, Volume: 69, Issue:12
Abietane diterpenoids from Salvia pachyphylla and S. clevelandii with cytotoxic activity against human cancer cell lines.
AID1756063Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471597Antibacterial activity against Proteus mirabilis CECT 170 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756078Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID471355Antibacterial activity against Bacillus subtilis ATCC 6051 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID471602Cytotoxicity against human Hep2 cells at lag phase of growth after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID277540Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 at 650 uM2007Journal of natural products, Feb, Volume: 70, Issue:2
Bioactive diterpenes from Orthosiphon labiatus and Salvia africana-lutea.
AID1756064Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1246300Cytotoxicity against human HepG2 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID744358Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons at 25 uM after 48 hrs by human placental alkaline phosphatase reporter gene assay relative to control2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1756080Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756082Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756077Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1357408Inhibition of mPGES1 in human A549 cell microsomal membrane using pGH2 as substrate pretreated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC method2018European journal of medicinal chemistry, Jun-10, Volume: 153Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation.
AID1756061Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID471353Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID1756079Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1246298Antiproliferative activity against human triple-negative MDA-MB-231 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1756081Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID471354Antibacterial activity against Staphylococcus epidermidis ATCC 14990 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
AID380265Cytotoxicity against human HBL100 cells after 48 hrs by SRB assay2006Journal of natural products, Dec, Volume: 69, Issue:12
Abietane diterpenoids from Salvia pachyphylla and S. clevelandii with cytotoxic activity against human cancer cell lines.
AID471599Antibacterial activity against Salmonella CECT 4569 after 24 hrs by broth dilution assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Semisynthesis and biological evaluation of abietane-type diterpenes. Revision of the structure of rosmaquinone.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (189)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's15 (7.94)18.2507
2000's40 (21.16)29.6817
2010's103 (54.50)24.3611
2020's31 (16.40)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.54 (24.57)
Research Supply Index5.27 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index61.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.52%)5.53%
Reviews12 (6.22%)6.00%
Case Studies2 (1.04%)4.05%
Observational0 (0.00%)0.25%
Other178 (92.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]